Emerald Advisers, LLC Mannkind Corp Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$3.34 - $4.29 $5.81 Million - $7.47 Million	-1,740,690 Reduced 59.01%	1,209,044 $4.4 Million
Q3 2023 Oct 26, 2023	SELL	$3.91 - $5.45 $10.9 Million - $15.2 Million	-2,796,985 Reduced 48.67%	2,949,734 $12.2 Million
Q2 2023 Jul 25, 2023	BUY	$3.72 - $4.79 $7.85 Million - $10.1 Million	2,111,510 Added 58.08%	5,746,719 $23.4 Million
Q1 2023 May 04, 2023	SELL	$3.95 - $5.63 $314,258 - $447,917	-79,559 Reduced 2.14%	3,635,209 $14.9 Million
Q4 2022 Feb 03, 2023	SELL	$3.02 - $5.37 $152,558 - $271,270	-50,516 Reduced 1.34%	3,714,768 $19.6 Million
Q3 2022 Oct 25, 2022	SELL	$2.99 - $4.35 $3.68 Million - $5.35 Million	-1,230,197 Reduced 24.63%	3,765,284 $11.6 Million
Q2 2022 Jul 29, 2022	SELL	$2.67 - $4.77 $1.82 Million - $3.24 Million	-680,058 Reduced 11.98%	4,995,481 $19 Million
Q1 2022 Apr 29, 2022	BUY	$2.62 - $4.45 $1.2 Million - $2.04 Million	458,502 Added 8.79%	5,675,539 $20.9 Million
Q4 2021 Feb 02, 2022	BUY	$4.05 - $5.37 $4 Million - $5.3 Million	987,748 Added 23.35%	5,217,037 $22.8 Million
Q3 2021 Oct 28, 2021	BUY	$3.89 - $5.48 $5.46 Million - $7.68 Million	1,402,357 Added 49.61%	4,229,289 $18.4 Million
Q2 2021 Jul 29, 2021	BUY	$3.61 - $5.45 $10.2 Million - $15.4 Million	2,826,932 New	2,826,932 $15.4 Million
Q4 2020 Jan 29, 2021	SELL	$1.79 - $4.04 $5.65 Million - $12.8 Million	-3,156,685 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$1.56 - $2.08 $2.18 Million - $2.9 Million	1,394,420 Added 79.13%	3,156,685 $5.94 Million
Q2 2020 Jul 28, 2020	BUY	$0.94 - $2.21 $1.66 Million - $3.89 Million	1,762,265 New	1,762,265 $3.08 Million

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account